Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database.
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | COART, Elisabeth | |
dc.contributor.author | SAAD, Everardo D. | |
dc.contributor.author | SHI, Qian | |
dc.contributor.author | SOMMEIJER, Dirkje Willemien | |
dc.contributor.author | ZALCBERG, John Raymond | |
dc.contributor.author | MAUGHAN, Tim | |
dc.contributor.author | GOLDBERG, Richard M. | |
dc.contributor.author | SCHMOLL, Hans-Joachim | |
dc.contributor.author | PUNT, Cornelis J. A. | |
dc.contributor.author | CUTSEM, Eric Van | |
dc.contributor.author | DOUILLARD, Jean-Yves | |
dc.contributor.author | HOFF, Paulo Marcelo | |
dc.contributor.author | TEBBUTT, Niall C. | |
dc.contributor.author | FUCHS, Charles S. | |
dc.contributor.author | FALCONE, Alfredo | |
dc.contributor.author | TOURNIGAND, Christophe | |
dc.contributor.author | GRAMONT, Aimery De | |
dc.contributor.author | SARGENT, Daniel J. | |
dc.contributor.author | BURZYKOWSKI, Tomasz | |
dc.contributor.author | BUYSE, Marc E. | |
dc.contributor.groupauthor | ARCAD Grp | |
dc.date.accessioned | 2015-08-27T12:51:46Z | |
dc.date.available | 2015-08-27T12:51:46Z | |
dc.date.issued | 2015 | |
dc.description.conferencedate | JAN 15-17, 2015 | |
dc.description.conferencelocal | San Francisco, CA | |
dc.description.conferencename | Gastrointestinal Cancers Symposium | |
dc.description.index | MEDLINE | |
dc.identifier.citation | JOURNAL OF CLINICAL ONCOLOGY, v.33, n.3, suppl.S, 2015 | |
dc.identifier.eissn | 1527-7755 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/10227 | |
dc.language.iso | eng | |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | |
dc.relation.ispartof | Journal of Clinical Oncology | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright AMER SOC CLINICAL ONCOLOGY | |
dc.subject.wos | Oncology | |
dc.title | Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. | |
dc.type | conferenceObject | |
dc.type.category | meeting abstract | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Austrália | |
hcfmusp.affiliation.countryiso | au | |
hcfmusp.author.external | BUYSE, Marc E.:Austin Hlth, Melbourne, Vic, Australia | |
hcfmusp.contributor.author-fmusphc | PAULO MARCELO GEHM HOFF | |
hcfmusp.description.issue | 3 | |
hcfmusp.description.issue | suppl S | |
hcfmusp.description.volume | 33 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000356883800661 | |
hcfmusp.publisher.city | ALEXANDRIA | |
hcfmusp.publisher.country | USA | |
relation.isAuthorOfPublication | 706efa42-09fc-4065-8330-9391f2cbe840 | |
relation.isAuthorOfPublication.latestForDiscovery | 706efa42-09fc-4065-8330-9391f2cbe840 |